arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

OmniAb, Inc.

OABI
$3.06 ▲ +0.79 (+35.10%) at close
Industrials ·Services-Commercial Physical & Biological Research ·USServices-Commercial Physical & Biological Research
26 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
18
Health
Poor
Bearish
auto_awesome

Analytical Summary

OmniAb, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $392.4M
Dividend Yield
Revenue Growth 247.3%
Op. Margin -54.3%
ROIC -3.2%
FCF / Share $-0.04
Trailing P/E
Price / Book 1.7x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$14.43M
↑ +247.3%
Net Income Profit after all expenses
$-7.71M
↑ +57.7%
Operating Margin Operating profit as % of sales
-54.3%
↑ +71.2% 0th
FCF / Share Free cash flow per share
$-0.04
↑ +74.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
0
Returns
26
Cash Quality
43

Dividend History

Dividend / share · sourced from SEC filings
$2.50 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters